INTRODUCTION
Evaluation of the cognitive function of patients in the emergency department (ED) has generally been limited by the time required for performance of cognitive function tests. The most popular tests used by psychiatrists include the Kahn's Mental Status Questionnaire (Kahn et al., 1960) , the Mini-Mental State Examination by Folstein (Folstein et al., 1975) , the Short Portable Mental Status Questionnaire by Pfeiffer (Pfeiffer, 1975) , the Cognitive Capacity Screening Examination by Jacobs (Jacobs et al., 1977) , and the Mattis Dementia Rating Scale (Mattis, 1976) . These tests require a minimum of five and often up to 15 minutes to administer in alert co-operative patients (Nelson et al., 1986) . Some skill on the part of the examiner and considerable persistence on the part of the patient are required. Hence these empiric mental status examinations are seldom used in the emergency department.
Zun & Gold (1986) recently surveyed emergency physicians to determine the form and content of their mental status examination. They found that 19% of American Board of Emergency Medicine certified physicians never performed a mental status examination while another 20% used it 'occasionally.' Nearly all respondents (97%) stated they would use a short standardised mental status examination if one were shown useful in the ED. Zun & Gold also noted that no currently proposed mental status examination has been evaluated for use in the ED.
Because cognitive impairment may reflect significant underlying metabolic dysfunction of the cerebrum, we evaluated an Abbreviated Mental Status Examination (AMSE) for its ability to denote normal cognitive function in ambulatory patients presenting to the ED and its ability to identify reduced cognitive function in patients presenting with significant drug intoxication. A test which can identify significant cognitive dysfunction prior to the development of a comatose state should be beneficial in evaluation and monitoring of drug-induced metabolic cerebral dysfunction in the ED. We specifically addressed the question of whether the AMSE could serve as an early prognosticator of serious metabolic dysfunction in overdose patients.
METHODS

AMSE Development and Overview
Initially, we used a 30 question menu by Dick et al. (1984) to assess mental status in our urban teaching hospital ED population. Although the menu of Dick et al. is more easily administered than other mental status examinations, our patients were unable to complete the examination either because of illiteracy, a decreased attention span, or emotional instability. On reviewing the initial menu of questions, 10 inquiries or commands were consistently answered or performed correctly by patients who exhibited alert and oriented behaviour when admitted to the ED without an obvious altered mental status. These 10 inquiries or commands comprise the AMSE we evaluated ( Table 1) .
Evaluation of the AMSE proceeded in two steps. First, determination of the normal range of values was obtained in ambulatory patients presenting to our ED. Second, the AMSE was evaluated on patients with acute drug ingestion and correlated with the Glasgow Coma Scale (GCS) score and subsequent patient outcome measures. Although the GCS was originally devised for prognostication of head injured patients (Teasdale & Jennett, 1974) , it is commonly applied to other populations with cognitive impairment and hence represents an appropriate tool for comparison. Patients were subsequently categorised by presenting complaint and total scores were compared after grouping of patients with and without acute or chronic pain, with or without trauma, and with or without an underlying psychiatric disorder (e.g., major depression or schizophrenia). Group score rank orders were compared using the Kruskal-Wallis test. The 10 components of the AMSE score were assessed individually to determine the error rate for each component and to determine if there was a significant error rate difference amongst the components. Error rates were compared using a Chi-Square analysis. Stat Pak statistical software (Northwest Analytical Co., Portland, OR) was used with a significance level of P < 005 throughout.
Evaluation in Overdose Population
Patients presenting to an urban teaching hospital ED with an acute drug overdose were assessed by measurement of a presenting AMSE score and GCS score in the ED. No patients were excluded for unco-operativeness during this portion of the study. When a patient would not answer a question, the response was considered incorrect. Correlation of test scores was performed by linear regression analysis and statistical significance determined by the Pearson Moment Coefficient. Furthermore, the patient's GCS score on presentation and AMSE score were compared with outcome measures including the need for admission to the intensive care unit (ICU), intubation in the ED or ICU, and complications in the ICU (Table 2 ). The AMSE score and the GCS score were compared for sensitivity of prediction of outcome criteria using the binomial distribution for 95% confidence intervals and McNemar's test (Kramer & Feinstein, 1981) .
RESULTS
Determination of Normal Range
Two hundred and ninety six patients were scored to determine the normal range of the AMSE score. These patients had a mean (± standard deviation) total AMSE score of 8-80 + 1 50. The histogram for the frequency of total AMSE scores is shown (Fig. 1) . A score of less than seven was seen in 7% of the total population, whereas, a score of less than eight was seen in 17% of the population. Although the triage nurses were instructed to apply the test only to patients they considered neurologically intact, 16 of the 28 patients with a total AMSE score less than seven and 26 of the 56 patients with a total score less than eight were disorientated to either time, place, or date. Of the test items, 'subtraction by seven' had the most incorrect answers (43% of the time incorrect). The multiple stage commands and 'subtraction by two' were also missed significantly more frequently (incorrect 15-20% of the time) than the remainder of the test items.
Comparison of the groups with or without acute or chronic pain and trauma disclosed no significant differences in group score rank order (Table 3) was significant (P < 0-005). Of those without a psychiatric diagnosis, the mean score was 8-91 + 1-35. Of the patients with a psychiatric complaint, the mean score was 7-58±2-30.
Correlation with Outcome in Overdose Patients
A total of 375 overdose patients were assessed for a correlation of their AMSE and the GCS score. The patient population had a mean age of 29-8 years and was 43% male and F7ZF7I / Although the AMSE score is expected to be more sensitive for cognitive impairment than the GCS score, strong correlation between the GCS score and the AMSE score was anticipated and found in our patients with acute drug ingestion. In addition, we found a strong association with admiition to the ICU, intubation in the ED or ICU, and the presence of complications in the ICU. Hence, an AMSE score of 'seven or less' appears to represent a sensitive marker for significant drug-induced cognitive impairment. Although a low AMSE is not specific for acute drug intoxication (as seen in our population of ambulatory patients), when applied to the acute drug overdose population, the AMSE score does appear to be a sensitive prognosticator of adverse outcome.
We conclude that the AMSE is an empiric test rapidly performed which can be used to semiquantitatively denote cognitive impairment. Overdose patients with an AMSE score of 'seven or less' appear to be at greater risk for complications of their overdose than patients presenting with an AMSE score of 'eight or greater.' While we do not advocate that the AMSE be used as a criterion upon which to base treatment or disposition, the AMSE does appear to be a helpful prognosticator. Patients with a low AMSE should be monitored closely during their ED evaluation and therapy. The AMSE may prove to be a useful tool for objectively stratifying overdose patients with cognitive impairment. Further evaluation of the AMSE for screening other ED patient populations with potential for cognitive impairment appears warranted.
